Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio P Nunes

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Human Mutation|September 20, 2006
Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findingsIris Ahronowitz, Winnie Xin, Rosemary Kiely, et al.
The Laryngoscope|November 4, 2008
Laryngeal candidiasis mimicking malignancyFabio P Nunes, Todd Bishop, Manju L Prasad, et al.
Journal of Neuro-Oncology|November 1, 2008
A role for the p53 pathway in the pathology of meningiomas with NF2 lossZeNan Chang, Chin-Lin Guo, Iris Ahronowitz, et al.
Journal of Neurosurgery. Spine|February 8, 2011
Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patientsScott R Plotkin, Caroline C O'Donnell, William T Curry, et al.
Dermatology and Therapy|November 30, 2021
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16Jonathan I Silverberg, Mark Boguniewicz, Jill Waibel, et al.
American Journal of Clinical Dermatology|April 7, 2021
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical TrialsBrett King, Catherine Maari, Edward Lain, et al.
European Journal of Medical Genetics|March 29, 2014
Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndromeDanielle B Pier, Fabio P Nunes, Scott R Plotkin, et al.
JAMA Dermatology|May 12, 2021
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Andreas Wollenberg, et al.
Plos One|April 5, 2013
Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patientsFabio P Nunes, Vanessa L Merker, Dominique Jennings, et al.
American Journal of Clinical Dermatology|August 18, 2020
Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia AreataKathleen W Wyrwich, Helen Kitchen, Sarah Knight, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Human Mutation|September 20, 2006
Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findingsIris Ahronowitz, Winnie Xin, Rosemary Kiely, et al.
The Laryngoscope|November 4, 2008
Laryngeal candidiasis mimicking malignancyFabio P Nunes, Todd Bishop, Manju L Prasad, et al.
Journal of Neuro-Oncology|November 1, 2008
A role for the p53 pathway in the pathology of meningiomas with NF2 lossZeNan Chang, Chin-Lin Guo, Iris Ahronowitz, et al.
Journal of Neurosurgery. Spine|February 8, 2011
Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patientsScott R Plotkin, Caroline C O'Donnell, William T Curry, et al.
Dermatology and Therapy|November 30, 2021
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16Jonathan I Silverberg, Mark Boguniewicz, Jill Waibel, et al.
American Journal of Clinical Dermatology|April 7, 2021
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical TrialsBrett King, Catherine Maari, Edward Lain, et al.
European Journal of Medical Genetics|March 29, 2014
Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndromeDanielle B Pier, Fabio P Nunes, Scott R Plotkin, et al.
JAMA Dermatology|May 12, 2021
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Andreas Wollenberg, et al.
Plos One|April 5, 2013
Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patientsFabio P Nunes, Vanessa L Merker, Dominique Jennings, et al.
American Journal of Clinical Dermatology|August 18, 2020
Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia AreataKathleen W Wyrwich, Helen Kitchen, Sarah Knight, et al.
Pageof 3